Role of the apoptotic and mitotic regulator survivin in melanoma

Jodi A McKenzie1, Douglas Grossman

  • 1Huntsman Cancer Institute, 2000 Circle of Hope Drive, Suite 5262, Salt Lake City, UT 84112, USA.

Anticancer Research
|January 31, 2012
PubMed

Insights

Survivin, a protein linked to cancer, plays a key role in melanoma development and metastasis. Understanding survivin

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Melanoma, the deadliest skin cancer, arises from oncogenic transformation of melanocytes.
  • Metastasis is the primary cause of melanoma-related mortality, underscoring the need to understand its progression.
  • Survivin, identified in the late 1990s, is implicated in various cancers.

Purpose of the Study:

  • To review the role of survivin in melanoma biology, development, and progression.
  • To discuss survivin's established functions and newly recognized properties.
  • To explore therapeutic strategies targeting survivin in melanoma.

Main Methods:

  • Literature review of scientific publications on survivin and melanoma.
  • Analysis of survivin's known mitotic and cytoprotective roles.
  • Examination of survivin's potential contribution to melanoma metastasis and cellular motility.

Main Results:

  • Survivin exhibits established roles in mitosis and cell protection.
  • Survivin enhances cellular motility, a property potentially driving melanoma metastasis.
  • A significant body of research demonstrates survivin's involvement in various malignancies.

Conclusions:

  • Survivin is a critical factor in melanoma development, progression, and metastasis.
  • Targeting survivin presents a promising therapeutic strategy for melanoma treatment.
  • Further research into survivin's role in cellular motility is warranted.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.